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The aromatic amines 2-aminofluorene (2AF), 2-acetylaminofluorene, and 2-aminoanthracene, and the heterocyclic amines 2-amino-3-methylimi-
dazo[4,5-flquinoline (IQ), 2-amino-3,4-dimethylimidazo[4,5-flquinoline, and 3-amino-i-methyl-SH-pyrido[4,3-blindole (Trp-P-2) were activated by rat
liver cytosolic fractions to form mutagenic metabolites in Salmonella typhimurium strains TA98, TA98NR, and TA98/1,8-DNP6. In the case of the
Trp-P-2, the cytosolic activation was even more potent than the microsomal activation, which is classically ascribed to N-hydroxylation and subsequent
esterification. The cytosolic activation was a) NADPH-dependent, b) induced by pretreatment of rats with 3-methylcholanthrene and especially
Aroclor 1254 but not by phenobarbital, and c) inhibited by dicoumarol. The hypothesis is that, following a preliminary oxidative step in the cytosol (pure
cytosolic activation) or in microsomes via prostaglandin H synthase (mixed microsomal-cytosolic activation), an oxidized intermediate of amino com-
pounds may serve as substrate for DT diaphorase activity and bielectronically reduced to the corresponding N-hydroxyamino derivative. Purified DT
diaphorase, in the presence of either NADPH or NADH as electron donor, produced mutagenic derivatives from IQ and Trp-P-2. An NADPH-dependent
activation of Trp-P-2 also occurred in the liver cytosol of woodchucks (Marmota monax4, but was not inhibited by dicoumarol. As previously demon-
strated with liver S-12 fractions in both humans and woodchucks, the cytosolic activation ofTrp-P-2 was enhanced in animals affected by hepatitis B
virus infection. This enhanced metabolism, which persisted even after appearance of primary hepatocellular carcinoma in virus carriers, is likely to be
ascribed to mechanisms other than DT diaphorase induction, such as glutathione depletion. - Environ Health Perspect 102(Suppl 6):69-74 (1994)
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Introduction
The first metabolic step in the hepatic acti-
vation of mutagenic and carcinogenic aro-
matic amines (1) and of food-derived
heterocyclic amines (2) consists in the
microsomal oxidation of the exocyclic
amino group, which is primarily catalyzed
by cytochromes P4501A1 and especially
P4501A2 (3). The N-hydroxyamino deriv-
atives are further esterified to form more
reactive species, [e.g., via O-sulfation (4) or
O-acylation, which takes place both in
mammalian liver cytosol (5) and bacterial
cells (6)]. An alternative pathway, especially
in extrahepatic tissues, proceeds via one-
electron oxidation catalyzed by microsomal
prostaglandin H synthase (PHS) (7,8).
Less attention has been paid to the
exclusive activation of these compounds in
the liver cytosol, although an activation of
aromatic amines to mutagenic metabolites
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has already been reported to occur in the
presence of rat liver cytosolic fractions in
bacterial test systems (9-11).
We present herein the results ofstudies
investigating the liver cytosolic metabolism
of the aromatic amines 2-aminofluorene
(2AF), 2-acetylaminofluorene (2AAF) and
2-aminoanthracene (2AA), and ofthe hete-
rocyclic amines 2-amino-3-methylimi-
dazo[4,5-f]quinoline (IQ), 2-amino-3,4-
dimethylimidazo[4,5-f]quinoline (MeIQ)
and 3-amino-1-methyl-SH-pyrido[4,3-b]-
indole (Trp-P-2). The cytosolic activation of
all these compounds was inhibited by dicou-
marol, a rather specific inhibitor of DT
diaphorase activity (12). Addition ofpurified
DT diaphorase, using either NADH or
NADPH as electron donor, produced muta-
genic derivatives ofheterocyclic amines. In
addition, in agreement with a previous
study using S-12 fractions (13), the activa-
tion ofTrp-P-2 by liver S-105 fractions
was enhanced in woodchucks naturally
infected with hepatitis B virus (WHV).
Materials and Methods
Chemicals andBiochemicals
Test mutagens included the heterocyclic
amines Trp-P-2, IQ, and MeIQ (gifts ofT
Sugimura and K Wakabayashi, National
Cancer Center Research Institute, Tokyo,
Japan), and the aromatic amines 2AF (Ega-
Chemie KG, Steinheim/Albuch, Germany),
2AAF and 2AA (both from Sigma
Chemical Co., St. Louis, MO). All test
mutagens were dissolved and diluted in
dimethylsulfoxide (DMSO). Dicoumarol
(Sigma) was dissolved in 0.01 N NaOH.
DT diaphorase (EC 1.6.99.2), purified
from the liver cytosol of 3-methylcholan-
threne-treated rats (14), was a gift from L
Ernster, C Lind, and J Segura Aguilar
(Arrhenius Laboratory, University of
Stockholm, Sweden). Its molecular activity,
as assayed with menadione as substrate
(15), was 72,500 mole/mole FAD/min.
AA
Four groups (five animals each) of male
adult Sprague-Dawley rats (Morini strain)
were either untreated or treatedwith one of
the following inducers (all ofthem diluted
in corn oil): phenobarbital (Merck AG,
Darmstadt, Germany) 3 ip injections of60
mg/kg during the 3 days before killing, 3-
methylcholanthrene (Fluka AG, Buchs,
Switzerland) single ip injection of 80
mg/kg 24 hr before killing, or Aroclor
1254 (Monsanto Co., St. Louis, MO) sin-
gle ip injection of500 mg/kg 5 days before
killing.
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The livers of 17 woodchucks (Marmota
monax), either uninfected or infected with
WHV or additionally carrying primary
hepatocellular carcinoma (PHC), were
kindly supplied by I Millman (Fox Chase
Cancer Center, Institute for Cancer
Research, Philadelphia, PA).
Preparation ofLiverSubceliular
Fractions
Liver preparations were obtained as previ-
ously described (16). They included: a)
whole cell homogenates, obtained by
homogenizing, in a Potter-Elvehjem appa-
ratus, minced livers in a 50 mM Tris-
0.25 M sucrose solution, pH 7.4 (3 ml/g
wet tissue); b) S-12 fractions, i.e., super-
natants obtained by twice centrifuging cell
homogenates for 20 min at 12,000g; c)- S-
105 or cytosolic fractions, i.e., supernatants
obtained by centrifuging S-12 fractions for
1 hr at 105,000g; and d) microsomal frac-
tions, i.e., the corresponding pellets, washed
once and resuspended in a 50 mM Tris
0.1 M EDTA solution, pH 7.4, supple-
mented with 20% glycerol (0.5 mg/g of
original tissue). All the cell preparations
were divided into small aliquots and
immediately stored at -80°C until use. For
use in mutagenicity assays, liver prepara-
tions were thawed and incorporated, in
varying amounts, into S-9 mix, i.e., an
NADPH-generating system composed of 8
mM MgCl2, 33 mM KCl, 5 mM G6P, 4
mM NADP+ and 100 mM sodium phos-
phate, pH 7.4; in assays with microsomes
this mix was supplemented with yeast
G6PD (8 IU/ml).
MutagenicityAssays
The mutagenicity oftest compounds in the
presence ofthe above described metabolic
systems, at the doses indicated under
Results, was evaluated in the Salmonella
reversion test, according to the plate incor-
poration procedure (17), using the S.
typhimurium strains TA98 (gift of BN
Ames, University of California, Berkeley,
CA) and its nitroreductase- or O-acetyl-
transferase-deficient derivatives TA98NR
and TA98/1,8-DNP6 (gifts of H.S.
Rosenkranz, University ofPittsburgh, PA).
Briefly, two consecutive preincubation
steps were performed, the first (10 min at
370C) involving the mixture of 500 pl
either of metabolic systems or its control
(lacking liver preparations and/or cofac-
tors) with 100 pl of either dicoumarol or
its solvent, the second (30 min at 37°C)
involving incubation with 100 pl ofeither
test mutagens or their controls (DMSO)
before plating in top agar with the appro-
priate Salmonella strain. All the assays were
performed in triplicate plates.
Results
The mutagenicity assay ofthe heterocyclic
amines Trp-P-2, IQ, and MeIQ in strain
S-12 fractions
TA98 ofS. typhimurium, in the presence of
varying amounts ofliver subcellular frac-
tions from Aroclor-treated rats (Figure 1),
showed that the activation by reconstituted
cytosolic plus microsomal fractions is even
greater than that produced by the original
postmitochondrial fractions. In addition,
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Figure 1. Metabolic activation of Trp-P-2 (20 ng/plate), 2-amino-3-methylimidazo[4,5,-f]quinoline (IQ) (8 ng/plate)
and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline(MeIQ) (2 ng/plate) to mutagenic metabolites in strain TA98 of S.
typhimurium, in the presence of varying amounts of liver post-mitochondrial (S-12), cvtosolic (S-105), microsomal,
or reconstituted cytosolic plus microsomal fractions from Aroclor-treated rats. The assays were carried out either
in the presence (--*) or in the absence (0--O) of 50 pM dicoumarol.
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Figure 2. Metabolic activation of Trp-P-2 (20 ng/plate), 2-amino-3-methylimidazo[4,5,-flquinoline(IQ) (8 ng/plate)
and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline(MeIQ) (2 ng/plate) to mutagenic metabolites in strain TA98 of S.
typhimurium, in the presence ofvarying amounts of liver cytosolic fractions from either uninduced, phenobarbital-,
3-methylcholanthrene- or Aroclor 1254-induced rats. The assays were carried out either in the presence (- ) or
in the absence (0--O) of 50 pM dicoumarol.
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Figure 3. Decrease of Trp-P-2 (20 ng/plate) mutagenic- or in the absence (open columns) of 50 pM dicoumarol.
ity in strain TA98 of S. typhimurium, in the presence of
liver cytosolic fractions (50 p1/plate) from Aroclor-
treated rats, as related to the amounts of dicoumarol
(5-50 pM).
cytosolic fractions were as active (IQ and
MeIQ) or even more active (Trp-P-2) than
the corresponding microsomal fractions, at
equivalent weight of liver, in activating
these heterocyclic amines. The addition of
dicoumarol resulted in an evident decrease
ofthe mutagenicity ofall three compounds,
and especially ofTrp-P-2, in the presence
of S-12, S-105, or S-105 plus microsomal
fractions, but not in the presence of pure
microsomal fractions (Figure 1). As
assessed with Trp-P-2, the activation by
either S-12 or S-105 fractions was inter-
changeably NADPH- or NADH-depen-
dent, the mutagenic response being poor
when no pyridine nucleotide was included
in the composition of S-9 mix (data not
shown).
As shown in the experiment reported in
Figure 2, the cytosolic activation ofTrp-P-2,
IQ, and MeIQ to mutagenic metabolites
was poor when liver preparations from
either untreated or phenobarbital-treated
rats were used; whereas, metabolism was
stimulated by pretreatment of rats with 3-
methylcholanthrene and even more with
Aroclor 1254. Again, addition ofdicoumarol
inhibited the cytosolic activation of these
heterocyclic amines, to a marked extent in
the case of Trp-P-2. Inhibition by
dicoumarol was dose-dependent (Figure 3).
The mutagenicity ofTrp-P-2 in the pres-
ence ofrat liver S-12 or S-105 fractions was
similar in the S. typhimurium strains TA98
and TA98NR; whereas, it was decreased but
not abolished (about halfin the experiment
shown in Figure 4) in TA98/1,8-DNP6.
Inhibition by dicoumarol was evident and
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Figure 5. Mutagenicity of varying amounts of the aro-
matic amines 2-aminofluorene, 2-acetylaminofluorene,
and 2-aminoanthracene in strain TA98 of S.
typhimurium after activation by either S-12 (0,0) or S-
105 (A,A) fractions from Aroclor-treated rats, either in
the absence (0,A) or presence (-,A) of 50 pM
dicoumarol. Based on preliminary dose-response
curves, 10 pl S-12 and 20 pl S-105 were used for 2AF
and 2AA activation, whereas 40 pl S-12 and 80 pl S-
105 were used for 2AAF activation.
Table 1. Mutagenicity in strain TA98 of S. typhimurium of heterocyclic amines in the presence of either NADH or
NADPH and purified DT diaphorase, and its inhibition bydicoumarol.'
Exp. Compound, Electron Purified Revertants per plate
no. 10 pg/plate donor DT diaphorase NaOH 50 pM dicoumarol
1 IQ NADH(4mM) 120 ±3 141 ±23
+(1U) 312 [x2.6] 139 [x1.0]
2 IQ NADH (4mM) 44±11 47 ±8
+(2U) 203 [x4.6] NT
+(1U) 128 x2.9] NT
+(0.5U) 105 [x2.4] NT
3 IQ NADPH (4 mM) 62±14 59± 11
+ (2U) 203 [x3.3] 74 [x1.2]
NADH (4 mM) 73 ±8 66± 19
+(2U) 171 [x2.3] 88[x1.3]
4 IQ NADPH (4mM) 85± 22 93 ± 15
+(1U) 173 [x2.0] 97[x.0]
NADH (4mM) 67 ± 10 64±9
+(1U) 126[x1.9] 71 [x.1]
5 Trp-P-2 NADPH (4mM) - 44 ± 8 51 ± 7
+(1U) 91 [x2.1] 54 [xl.1]
aResults are expressed as mean SD oftriplicate plates in the absence of DT diaphorase and of individual results in
its presence. Values between brackets indicate the relative increase of revertants produced bythe pure enzyme.
significant (p<0.001, as assessed by Student's
t-test) in all three strains (Figure4).
Four separate experiments with IQ and
one experiment with Trp-P-2 indicated
that addition ofpurified DT diaphorase, in
the presence ofeither NADH or NADPH
as electron donor, resulted in a poor (from
1.9- to 4.6-fold) yet reproducible and dose-
dependent enhancement of mutagenicity,
whichwas inhibited bydicoumarol (Table 1).
Similar indications were provided by
experiments with the aromatic amines
2AF, 2AAF, and 2AA, shown in Figure 5.
All three compounds were activated not
only by S-12 but also by rat liver S-105
fractions, and dicoumarol produced a sig-
nificant decrease ofmutagenicity.
The activation ofTrp-P-2 to mutagenic
metabolites was also obtained in the pres-
ence ofwoodchuck liver S-105 fractions
(Figure 6). The results ofthese experiments
are expressed as relative metabolic effi-
ciency (RME), i.e., the ratio ofmean rever-
tants induced by Trp-P-2 in the presence
ofeach liver preparation to mean revertants
induced by Trp-P-2 in the presence of S-
105 buffer. In spite of a considerable
interindividual variability, activation by
liver S-105 fractions from WHV-infected
animals (mean ± SD = 6.8 ± 3.83) was sig-
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Figure 7. Correlation between metabolic activation by
woodchuck liver S-105 fractions (Figure 6) and meta-
bolic activation by the corresponding S-12 fractions
(13).
tester strains, irrespective oftheir sensitivity
to this compound, which was similar in
TA98 and its nitroreductase-deficient
derivative TA98NR, and lower (yet still
appreciable) in the O-acetyltransferase-defi-
cient derivative TA98/1,8-DNP6. This
suggests that the results obtained in the
presence ofliversubfractions are not affected
by further metabolism in bacterial cells.
All these patterns converge in suggesting
a possible role of DT diaphorase in the
cytosolic activation ofaromatic and hetero-
cyclic amines. In fact, this FAD-containing
flavoprotein is mostly localized in the cell
cytosol, where it utilizes both reduced
pyridine nucleotides as electron donors,
dicoumarol being the most potent inhibitor
(12). Moreover, DT diaphorase is induced
in rat liver cytosol by 3-methylcholan-
threne and even more byAroclor 1254, but
not by phenobarbital (25,26). However,
an involvement of DT diaphorase in the
metabolism of amino compounds is diffi-
cult to be interpreted, because it is obvious
that these molecules cannot per se accept
electrons. We raise the hypothesis that the
amino group may undergo a preliminary
oxidation to form an intermediate, acting as
a substrate for DT diaphorase. For instance,
as shown with pyrolysis products oftrypto-
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Figure 6. Metabolic activation of Trp-P-2 (1 pg/plate) in strain TA98 of S. typhimurium by liver S-105 fractions
(amounts corresponding to 2 mg S-105 protein/plate) from captive woodchuck either uninfected with hepatitis B
virus(WHy-) or infected with hepatitis Bvirus(WHV+) oradditionally bearing primary hepatocellular carcinoma (PHC+).
nificantly greater than that from uninfected
animals (2.7 ± 0.55) (p<0.05, as assessed
by Student's t-test). The former value did
not significantly differ from that produced
by the nontumorous tissue preparations of
WHV carriers bearing PHC (4.6 ± 1.57).
Within this group of animals, the liver
cytosol from the cancer tissue was signifi-
cantly less efficient in activating Trp-P-2
than the surrounding nontumorous tissue
(p<0.05, as assessed by Student's t-test for
paired data). Activation by woodchuck
liver cytosol was almost exclusively NADPH
dependent, but was not affected by addi-
tion ofdicoumarol (data not shown).There
was a high (r = 0.88) and significant
(p<0.001) correlation between activation
by woodchuck liver S-105 fractions, as
reported in the present study, and activa-
tion by the corresponding S-12 fractions,
as it had been reported in a previous study
(13) (Figure 7).
Discussion
The results of the present study provide
evidence that liver cytosol can contribute to
the activation not only ofaromatic amines,
thus confirming the findings reported by
other laboratories (9-11), but also ofhete-
rocyclic amines. The production of muta-
genic metabolites by microsomal and
cytosolic fractions was ofthe same order of
magnitude for the two imidazoquinolines;
whereas, cytosolic fractions were even more
effective than microsomal fractions in acti-
vating the tryptophan pyrolysis product.
In any case, as assessed with all three
heterocyclic amines, the mutagenic response
obtained in the presence ofcytosolic and
microsomal fractions was less than additive,
as compared to the effect ofthe original S-12
fractions. At least in the case ofTrp-P-2,
activation was even better by reconstituting
cytosolic and microsomal fractions. These
results suggest that, besides an exclusive
cytosolic metabolism, an interaction
between microsomal and cytosolic pathways
can also occur, such interation being better
expressed when the two subfractions are
reconstituted in the experimental system
used. The potentiating effect ofthe cytosol
towards microsomal activation had been
previously reported with aromatic and het-
erocyclic amines, such as 3-amino-5H-
pyrido[4,3-b]indole (18), 2AF (19), and
IQ (20). However, in the last two studies
the cytosol alone failed to activate 2AF and
IQ. In another laboratory, where 2AF,
2AAF, and 2AA had been reported to be
activated by the cytosol alone (9), the
cytosol was also found to enhance the S-9
activation ofthe same compounds (21).
The cytosolic activation of IQ, MeIQ,
Trp-P-2, 2AF, 2AAF, and 2AA, as assessed
in the present study, was a) NADPH
dependent, b) uninduced by phenobarbital
but induced by 3-methylcholanthrene and,
even more, byArodor 1254, and c) inhibited
by dicoumarol, with top efficiency in the
case ofTrp-P-2. Dicoumarol decreased the
mutagenic response induced in the presence
ofeither S-12 or S-105 fractions but not in
the presence ofmicrosomes. In preliminary
assays carried out in our laboratory, the S-
12-mediated mutagenicity of MeIQ and
Trp-P-2 and, in addition, of a cigarette
smoke condensate [which among other
compounds contains heterocyclic amines
(22) and various quinones (23)] had been
found to be decreased by dicoumarol (24).
Inhibition by dicoumarol of S-12 and S-
105 activation ofTrp-P-2 occurred in all
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phan and glutamic acid, heterocyclic
amines can be oxidized in the cytosol by
hydrogen peroxide plus various peroxidases
or catalase (27,28). Alternatively, as
reported in the Introduction, amines can
undergo a one-electron oxidation catalyzed
by microsomal PHS (7,8), which can
explain a combined microsomal-cytosolic
activation ofthese compounds. It has been
reported that PHS can oxidize 2AF to 2-
nitrofluorene (29), and possibly IQ to
nitro-IQ(30).
It is likely that N-hydroxy c'ompounds
are common metabolites to heterocyclic
amines and their nitroderivatives, via
monooxygenases and nitroreductases,
respectively (31). In this study, however,
bacterial nitroreductases did not affect the
cytosolic activation ofTrp-P-2. Therefore,
we propose that, following a preliminary
oxidation to the nitroso- or the nitro-deriv-
ative, either in the cytosol or in the endo-
plasmic reticulum, DT diaphorase may
catalyze one or two consecutive two-electron
reductions, as it is typical for this enzyme
activity (at least with quinones) (32). The
weak yet consistent generation ofmutagenic
derivatives following addition ofpurified
DT diaphorase to IQ or Trp-P-2, in the
presence of either NADH or NADPH,
may possibly be ascribed to traces of oxi-
dized amines in the reaction mixture. It is
noteworthy that DT diaphorase has already
been shown to metabolize nitrocom-
pounds, such as 4-nitroquinoline 1-oxide
(24,33) and dinitropyrenes (DNP) (34).
In the case of DNP isomers, activation by
liver cytosol contrasts with detoxification by
microsomal or S-12 fractions (34,35).
Extensive studies now in progress in our
laboratory show that the mutagenicity of
1,3-DNP, 1,6-DNP, and 1,8-DNP is
inhibited by rat liver S-12 or microsomal
fractions, irrespective ofAroclor induction,
as well as by cytosolic fractions from
Aroclor-treated rats. The mutagenicity of
1,3-DNP is considerably enhanced only by
using the cytosol from uninduced rats, with
an NADPH-dependent and dicoumarol-
inhibitable mechanism. The mutagenicity
ofall these compounds is also enhanced by
reduced glutathione (unpublished data).
Trp-P-2 was also activated by the liver
cytosol ofwoodchucks, and cytosolic activa-
tion correlated with S-12 activation, which
had been investigated in a previous study
using the same liver specimens (13). The
cytosolic activation was NADPH depen-
dent but was not inhibited by dicoumarol,
which rules out any involveient of DT
diaphorase in this rodent species. Therefore,
different mechanisms appear to be involved
in the cytosolic activation ofTrp-P-2 in rat
and woodchuck liver.
Previous studies using liver postmito-
chondrial fractions from patients affected
by chronic active hepatitis (36), wild-
caught woodchucks affected by chronic
active hepatitis (37), and the specimens of
captive woodchucks analyzed in this study
(13), had demonstrated that infection with
the specific hepadnaviruses, i.e., hepatitis B
virus (HBV) in humans and WHV in
woodchucks, results in an enhanced activa-
tion ofTrp-P-2 to mutagenic metabolites.
This inducing effect has been confirmed
now by using woodchuck liver cytosolic
fractions. Moreover, in agreement with the
data obtained by testing the corresponding
S-12 fractions, stimulation ofthe cytosolic
activation of Trp-P-2 in WHV-infected
animals persisted also after PHC forma-
tion. The cancer tissue itself, in accordance
with the resistant hepatocyte model (38),
exhibited a reduced Trp-P-2-activating abil-
ity, as compared to the surrounding non-
carcinogenic tissue. Since all these effects
were not affected by dicoumarol, and DT
diaphorase activity was not altered by
WHV infection (13), other cytosolic mech-
anisms, such as the marked depletion of
hepatocellular glutathione produced by
WHV (13), are likely to account for the
modulation of the cytosolic metabolism of
procarcinogens in viral hepatitis B.
Heterocyclic amines produce higher
levels of DNA adducts in the liver than in
other organs, which correlates with their
hepatocarcinogenicity (39). Taking into
account thathumans areexposed ubiquitously
to these compounds through the ingestion
ofcooked foods, an enhancement of their
metabolic activation in the liver ofhepad-
navirus carriers, both in the cytosol and the
endoplasmic reticulum, may bear relevance
in the etiopathogenesis of the PHC forms
associated with HBV infection.
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